Sucralfate does not ameliorate acute radiation proctitis: Randomised study and meta-analysis

Clinical Oncology

Volumn 17, Issue 6, 2005, Pages 485-491

  Hovdenak, Nils ^a   Sorbye H ^a   Dahl, O ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Prophylaxis; Radiation proctitis; Sucralfate

Indexed keywords

HYDROCORTISONE; MESALAZINE; PLACEBO; SUCRALFATE;

ABDOMINAL PAIN; ARTICLE; BLADDER TUMOR; BLOATING; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDLINE; META ANALYSIS; PELVIS TUMOR; PRIORITY JOURNAL; PROCTITIS; PROCTOSCOPE; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUMOR BIOPSY; UTERINE CERVIX CANCER;

ACUTE DISEASE; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; HUMANS; PELVIC NEOPLASMS; PROCTITIS; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY, HIGH-ENERGY; SUCRALFATE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 23744497271     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2005.04.011     Document Type: Article

References (42)

1. N. Hovdenak A. Karlsdottir H. Sorbye O. Dahl Profiles and time course of acute radiation toxicity symptoms during conformal radiotherapy for cancer of the prostate Acta Oncol 42 2003 741-748
2. D.M. Tait A.E. Nahum L. Rigby et al. Conformal radiotherapy of the pelvis: Assessment of acute toxicity Radiother Oncol 29 1993 117-126
3. R.R. Babb Radiation proctitis: A review Am J Gastroenterol 91 1996 1309-1311
4. O. Dahl D. Kardamakis B. Lind J.C. Rosenwald Current status of conformal radiotherapy Acta Oncol 35 1996 41-57
5. C.N. Coleman Radiation oncology: Linking technology and biology in the treatment of cancer Acta Oncol 41 2002 6-13
6. IMRT Collaborative Working Group Intensity-modulated radiotherapy: current status and issues of interest Int J Radiat Oncol Biol Phys 51 2003 880-914
7. L.P. Muren O. Mella R. Hafslund O. Dahl Norwegian oncologists' expectations of intensity-modulated radiotherapy Acta Oncol 41 2003 562-565
8. P. Lechner H. Cesnik Abdominopelvic omentopexy: Preparation procedure for radiotherapy in rectal cancer Dis Colon Rectum 35 1992 1157-1160
9. S.L. Jensen J.P. Funch Role of sucralfate in peptic disease Dig Dis 10 1992 153-161
10. S.J. Konturek T. Brzozowski J. Majka et al. Fibroblast growth factor in gastroprotection and ulcer healing: Interaction with sucralfate Gut 34 1993 881-887
11. M.R. Lucey J. Park J. DelValle L.D. Wang T. Yamada Sucrose octasulfate stimulates gastric somatostatin release Am J Med 91 1991 52S-57S
12. N. Hovdenak L.F. Fajardo M. Hauer-Jensen Acute radiation proctitis: A sequential clinicopathologic study during pelvic radiotherapy Int J Radiat Oncol Biol Phys 48 2000 1111-1117
13. S.B. Hanauer M. Robinson R. Pruitt et al. Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: A dose-ranging study. U.S. Budesonide enema study group Gastroenterology 115 1998 525-532
14. R. Henriksson M. Arevarn L. Franzen H. Persson U. Stendahl Beneficial effects of sucralphate in radiation induced diarrhea. An open randomized study in gynecological cancer patients Eur J Gynaecol Oncol 11 1990 299-302
15. R. Henriksson L. Franzen B. Littbrand Prevention of irradiation-induced bowel discomfort by sucralfate: A double-blind, placebo-controlled study when treating localized pelvic cancer Am J Med 91 1991 151S-157S
16. A. Kneebone H. Mameghan T. Bolin et al. The effect of oral sucralfate on the acute proctitis associated with prostate radiotherapy: A double-blind, randomized trial Int J Radiat Oncol Biol Phys 51 2001 628-635
17. J.A. Martenson J.W. Bollinger J.A. Sloan et al. Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A North Central Cancer Treatment Group phase III double-blind placebo-controlled trial J Clin Oncol 18 2000 1239-1245
18. P.C. O'Brien C.I. Franklin K.B. Dear et al. A phase III double-blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis Radiother Oncol 45 1997 117-123
19. K. Stellamans Y. Lievens P. Lambin et al. Does sucralfate reduce early side effects of pelvic radiation? A double-blind randomized trial Radiother Oncol 65 2002 105-108
20. A. Valls I. Pestchen C. Prats et al. Multicenter double-blind clinical trial comparing sucralfate vs placebo in the prevention of diarrhea secondary to pelvic irradiation [in Spanish] Med Clin (Barc) 113 1999 681-684
21. G. Sanguineti P. Franzone M. Marcenaro F. Foppiano V. Vitale Sucralfate versus mesalazine versus hydrocortisone in the prevention of acute radiation proctitis during conformal radiotherapy for prostate carcinoma. A randomized study Strahlenther Onkol 179 2003 464-470
22. C.B. Begg J.A. Berlin Publication bias and dissemination of clinical research J Natl Cancer Inst 81 1989 107-115
23. B.A. Erickson M.F. Otterson J.E. Moulder S.K. Sarna Altered motility causes the early gastrointestinal toxicity of irradiation Int J Radiat Oncol Biol Phys 28 1994 905-912
24. D. Hollander A. Tarnawski The protective and therapeutic mechanisms of sucralfate Scand J Gastroenterol 25 1990 1-5
25. S. Nakazawa R. Nagashima I.M. Saniloff Selective binding of sucralfate to gastric ulcer in man Dig Dis Sci 26 1981 297-300
26. M. Romano M. Razandi K.J. Ivey Effect of sucralfate and its components on taurocholate-induced damage to rat gastric mucosal cells in tissue culture Dig Dis Sci 35 1990 467-476
27. S. Szabo P. Vattay E. Scarbrough J. Folkman Role of vascular factors, including angiogenesis, in the mechanisms of action of sucralfate Am J Med 91 1991 158S-160S
28. Z. Sandor M. Nagata S. Kusstatscher S. Szabo Stimulation of mucosal glutathione and angiogenesis: New mechanisms of gastroprotection and ulcer healing by sucralfate Scand J Gastroenterol Suppl 210 1995 19-21
29. M.G. Northway M.W. Scobey K.R. Geisinger Radiation proctitis in the rat. Sequential changes and effects of anti- inflammatory agents Cancer 62 1988 1962-1969
30. B.G. Taal R.A. Vales Olmos H. Boot C.A. Hoefnagel Assessment of sucralfate coating by sequential scintigraphic imaging in radiation-induced esophageal lesions Gastrointest Endosc 41 1995 109-114
31. D.J. Grdina J.S. Murley Y. Kataoka Radioprotectants: Current status and new directions Oncology 63 Suppl 2 2002 2-10
32. J.C. Lindegaard C. Grau Has the outlook improved for amifostine as a clinical radioprotector? Radiother Oncol 57 2000 113-118
33. J.C. Lindegaard Has the time come for routine use of amifostine in clinical radiotherapy practice? Acta Oncol 42 2003 2-3
34. T.H. Wasserman D.M. Brizel The role of amifostine as a radioprotector Oncology (Huntingt) 15 2001 1349-1354
35. E. Ben Josef S. Han M. Tobi et al. Intrarectal application of amifostine for the prevention of radiation-induced rectal injury Semin Radiat Oncol 12 2002 81-85
36. A.M. Khan J.W. Birk J.C. Anderson et al. A prospective randomized placebo-controlled double-blinded pilot study of misoprostol rectal suppositories in the prevention of acute and chronic radiation proctitis symptoms in prostate cancer patients Am J Gastroenterol 95 2000 1961-1966
37. H.R. Baillie-Johnson Octreotide in the management of treatment-related diarrhoea Anticancer Drugs 7 Suppl 1 1996 11-15
38. J. Wang H. Zheng C.C. Sung M. Hauer-Jensen The synthetic somatostatin analogue, octreotide, ameliorates acute and delayed intestinal radiation injury Int J Radiat Oncol Biol Phys 45 1999 1289-1296
39. J. Wang H. Zheng M. Hauer-Jensen Influence of short-term octreotide administration on chronic tissue injury, transforming growth factor beta (TGF-beta) overexpression, and collagen accumulation in irradiated rat intestine J Pharmacol Exp Ther 297 2001 35-42
40. M. Hauer-Jensen J. Wang J.W. Denham Mechanisms and modification of the radiation response of gastrointestinal organs In: C. Nieder L. Milas K.K. Ang eds. Modification of radiation response 2003 Springer-Verlag Berlin, Heidelberg, New York 49-72
41. M.W. Ferguson Skin wound healing: Transforming growth factor beta antagonists decrease scarring and improve quality J Interferon Res 14 1994 303-304
42. J. Wang C.M. Albertson H. Zheng L.M. Fink J.M. Herbert M. Hauer-Jensen Short-term inhibition of ADP-induced platelet aggregation by clopidogrel ameliorates radiation-induced toxicity in rat small intestine Thromb Haemost 87 2002 122-128